These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16386954)

  • 1. Genetic and phenotypic analysis of dilated cardiomyopathy with conduction system disease: demand for strategies in the management of presymptomatic lamin A/C mutant carriers.
    Perrot A; Sigusch HH; Nägele H; Genschel J; Lehmkuhl H; Hetzer R; Geier C; Leon Perez V; Reinhard D; Dietz R; Josef Osterziel K; Schmidt HH
    Eur J Heart Fail; 2006 Aug; 8(5):484-93. PubMed ID: 16386954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.
    Fatkin D; MacRae C; Sasaki T; Wolff MR; Porcu M; Frenneaux M; Atherton J; Vidaillet HJ; Spudich S; De Girolami U; Seidman JG; Seidman C; Muntoni F; Müehle G; Johnson W; McDonough B
    N Engl J Med; 1999 Dec; 341(23):1715-24. PubMed ID: 10580070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy.
    Kärkkäinen S; Heliö T; Miettinen R; Tuomainen P; Peltola P; Rummukainen J; Ylitalo K; Kaartinen M; Kuusisto J; Toivonen L; Nieminen MS; Laakso M; Peuhkurinen K
    Eur Heart J; 2004 May; 25(10):885-93. PubMed ID: 15140538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease.
    Jakobs PM; Hanson EL; Crispell KA; Toy W; Keegan H; Schilling K; Icenogle TB; Litt M; Hershberger RE
    J Card Fail; 2001 Sep; 7(3):249-56. PubMed ID: 11561226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy.
    Millat G; Bouvagnet P; Chevalier P; Sebbag L; Dulac A; Dauphin C; Jouk PS; Delrue MA; Thambo JB; Le Metayer P; Seronde MF; Faivre L; Eicher JC; Rousson R
    Eur J Med Genet; 2011; 54(6):e570-5. PubMed ID: 21846512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
    van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
    Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation.
    Hershberger RE; Hanson EL; Jakobs PM; Keegan H; Coates K; Bousman S; Litt M
    Am Heart J; 2002 Dec; 144(6):1081-6. PubMed ID: 12486434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy.
    Perrot A; Hussein S; Ruppert V; Schmidt HH; Wehnert MS; Duong NT; Posch MG; Panek A; Dietz R; Kindermann I; Böhm M; Michalewska-Wludarczyk A; Richter A; Maisch B; Pankuweit S; Ozcelik C
    Basic Res Cardiol; 2009 Jan; 104(1):90-9. PubMed ID: 18795223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional consequences of an LMNA mutation associated with a new cardiac and non-cardiac phenotype.
    Charniot JC; Pascal C; Bouchier C; Sébillon P; Salama J; Duboscq-Bidot L; Peuchmaurd M; Desnos M; Artigou JY; Komajda M
    Hum Mutat; 2003 May; 21(5):473-81. PubMed ID: 12673789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilated cardiomyopathy caused by LMNA mutations. Clinical and morphological studies.
    Bilińska ZT; Sylvius N; Grzybowski J; Fidziańska A; Michalak E; Walczak E; Walski M; Bieganowska K; Szymaniak E; Kuśmierczyk-Droszcz B; Lubiszewska B; Wagner T; Tesson F; Ruzyłło W
    Kardiol Pol; 2006 Aug; 64(8):812-9; discussion 820-1. PubMed ID: 16981056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
    Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
    PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene.
    Bonne G; Mercuri E; Muchir A; Urtizberea A; Bécane HM; Recan D; Merlini L; Wehnert M; Boor R; Reuner U; Vorgerd M; Wicklein EM; Eymard B; Duboc D; Penisson-Besnier I; Cuisset JM; Ferrer X; Desguerre I; Lacombe D; Bushby K; Pollitt C; Toniolo D; Fardeau M; Schwartz K; Muntoni F
    Ann Neurol; 2000 Aug; 48(2):170-80. PubMed ID: 10939567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamin A/C deficiency as a cause of familial dilated cardiomyopathy.
    Malhotra R; Mason PK
    Curr Opin Cardiol; 2009 May; 24(3):203-8. PubMed ID: 19384091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.
    Taylor MR; Slavov D; Gajewski A; Vlcek S; Ku L; Fain PR; Carniel E; Di Lenarda A; Sinagra G; Boucek MM; Cavanaugh J; Graw SL; Ruegg P; Feiger J; Zhu X; Ferguson DA; Bristow MR; Gotzmann J; Foisner R; Mestroni L;
    Hum Mutat; 2005 Dec; 26(6):566-74. PubMed ID: 16247757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
    Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
    Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel mutations in LMNA associated with familial forms of dilated cardiomyopathy.
    Stallmeyer B; Koopmann M; Schulze-Bahr E
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):543-9. PubMed ID: 22224630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
    Sylvius N; Bilinska ZT; Veinot JP; Fidzianska A; Bolongo PM; Poon S; McKeown P; Davies RA; Chan KL; Tang AS; Dyack S; Grzybowski J; Ruzyllo W; McBride H; Tesson F
    J Med Genet; 2005 Aug; 42(8):639-47. PubMed ID: 16061563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamin A/C and cardiac diseases.
    Sylvius N; Tesson F
    Curr Opin Cardiol; 2006 May; 21(3):159-65. PubMed ID: 16601451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe dilated cardiomyopathy and quadriceps myopathy due to lamin A/C gene mutation: a phenotypic study.
    Charniot JC; Desnos M; Zerhouni K; Bonnefont-Rousselot D; Albertini JP; Salama JZ; Bassez G; Komajda M; Artigou JY
    Eur J Heart Fail; 2006 May; 8(3):249-56. PubMed ID: 16314145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case reports of a c.475G>T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death.
    Yokokawa T; Ichimura S; Hijioka N; Kaneshiro T; Yoshihisa A; Kunii H; Nakazato K; Ishida T; Suzuki O; Ohno S; Aiba T; Ohtani H; Takeishi Y
    BMC Cardiovasc Disord; 2019 Dec; 19(1):298. PubMed ID: 31847799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.